The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer
<p style="text-align:justify;"> RNA-binding proteins (RBPs) are increasingly identified as post-transcriptional drivers of cancer progression. The RBP LARP1 is an mRNA stability regulator, and elevated expression of the protein in hepatocellular and lung cancers is correlated with a...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2015
|
_version_ | 1797050665019637760 |
---|---|
author | Hopkins, T Mura, M Al-Ashtal, H Lahr, R Abd-Latip, N Sweeney, K Lu, H Weir, J El-Bahrawy, M Steel, J Ghaem-Maghami, S Aboagye, E Berman, A Blagden, S |
author_facet | Hopkins, T Mura, M Al-Ashtal, H Lahr, R Abd-Latip, N Sweeney, K Lu, H Weir, J El-Bahrawy, M Steel, J Ghaem-Maghami, S Aboagye, E Berman, A Blagden, S |
author_sort | Hopkins, T |
collection | OXFORD |
description | <p style="text-align:justify;"> RNA-binding proteins (RBPs) are increasingly identified as post-transcriptional drivers of cancer progression. The RBP LARP1 is an mRNA stability regulator, and elevated expression of the protein in hepatocellular and lung cancers is correlated with adverse prognosis. LARP1 associates with an mRNA interactome that is enriched for oncogenic transcripts. Here we explore the role of LARP1 in epithelial ovarian cancer, a disease characterized by the rapid acquisition of resistance to chemotherapy through the induction of pro-survival signalling. We show, using ovarian cell lines and xenografts, that LARP1 is required for cancer cell survival and chemotherapy resistance. LARP1 promotes tumour formation in vivo and maintains cancer stem cell-like populations. Using transcriptomic analysis following LARP1 knockdown, cross-referenced against the LARP1 interactome, we identify BCL2 and BIK as LARP1 mRNA targets. We demonstrate that, through an interaction with the 3′ untranslated regions (3′ UTRs) of BCL2 and BIK, LARP1 stabilizes BCL2 but destabilizes BIK with the net effect of resisting apoptosis. Together, our data indicate that by differentially regulating the stability of a selection of mRNAs, LARP1 promotes ovarian cancer progression and chemotherapy resistance. </p> |
first_indexed | 2024-03-06T18:08:32Z |
format | Journal article |
id | oxford-uuid:02398593-4478-40cf-8821-4c5338857a8c |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-06T18:08:32Z |
publishDate | 2015 |
publisher | Oxford University Press |
record_format | dspace |
spelling | oxford-uuid:02398593-4478-40cf-8821-4c5338857a8c2022-03-26T08:39:32ZThe RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancerJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:02398593-4478-40cf-8821-4c5338857a8cEnglishSymplectic Elements at OxfordOxford University Press2015Hopkins, TMura, MAl-Ashtal, HLahr, RAbd-Latip, NSweeney, KLu, HWeir, JEl-Bahrawy, MSteel, JGhaem-Maghami, SAboagye, EBerman, ABlagden, S <p style="text-align:justify;"> RNA-binding proteins (RBPs) are increasingly identified as post-transcriptional drivers of cancer progression. The RBP LARP1 is an mRNA stability regulator, and elevated expression of the protein in hepatocellular and lung cancers is correlated with adverse prognosis. LARP1 associates with an mRNA interactome that is enriched for oncogenic transcripts. Here we explore the role of LARP1 in epithelial ovarian cancer, a disease characterized by the rapid acquisition of resistance to chemotherapy through the induction of pro-survival signalling. We show, using ovarian cell lines and xenografts, that LARP1 is required for cancer cell survival and chemotherapy resistance. LARP1 promotes tumour formation in vivo and maintains cancer stem cell-like populations. Using transcriptomic analysis following LARP1 knockdown, cross-referenced against the LARP1 interactome, we identify BCL2 and BIK as LARP1 mRNA targets. We demonstrate that, through an interaction with the 3′ untranslated regions (3′ UTRs) of BCL2 and BIK, LARP1 stabilizes BCL2 but destabilizes BIK with the net effect of resisting apoptosis. Together, our data indicate that by differentially regulating the stability of a selection of mRNAs, LARP1 promotes ovarian cancer progression and chemotherapy resistance. </p> |
spellingShingle | Hopkins, T Mura, M Al-Ashtal, H Lahr, R Abd-Latip, N Sweeney, K Lu, H Weir, J El-Bahrawy, M Steel, J Ghaem-Maghami, S Aboagye, E Berman, A Blagden, S The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer |
title | The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer |
title_full | The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer |
title_fullStr | The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer |
title_full_unstemmed | The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer |
title_short | The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer |
title_sort | rna binding protein larp1 is a post transcriptional regulator of survival and tumorigenesis in ovarian cancer |
work_keys_str_mv | AT hopkinst thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT muram thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT alashtalh thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT lahrr thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT abdlatipn thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT sweeneyk thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT luh thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT weirj thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT elbahrawym thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT steelj thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT ghaemmaghamis thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT aboagyee thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT bermana thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT blagdens thernabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT hopkinst rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT muram rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT alashtalh rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT lahrr rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT abdlatipn rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT sweeneyk rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT luh rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT weirj rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT elbahrawym rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT steelj rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT ghaemmaghamis rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT aboagyee rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT bermana rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer AT blagdens rnabindingproteinlarp1isaposttranscriptionalregulatorofsurvivalandtumorigenesisinovariancancer |